Table 3 Anesthetic agent use, depth of sedation and adverse events
Group RP | Group DP | p | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mean ± SD/n-% | Median | Mean ± SD /n-% | Median | ||||||||
Total Remifentanil (mcg) | 122.8 | ± | 51.7 | 120.0 | 78.2 | ± | 11.1 | 79.5 | 0.000 | t | |
Total time (min) | 19.1 | ± | 4.5 | 17.0 | 17.8 | ± | 3.1 | 16.5 | 0.161 | t | |
VAS Score | 1.08 | ± | 1.382 | 0.00 | 0.28 | ± | 0.70 | 0.00 | 0.003 | t | |
RSS | 5.3 | ± | 0.5 | 5.0 | 5.4 | ± | 0.5 | 5.0 | 0.298 | t | |
RSS > 4 time (min) | 2.11 | ± | 0.46 | 2.00 | 5.28 | ± | 0.66 | 5.00 | 0.000 | t | |
MAS > 9 time (min) | 1.81 | ± | 0.84 | 2.00 | 19.03 | ± | 2.16 | 19.00 | 0.000 | t | |
Desaturation | (-) | 6 | 16,2% | 27 | 75.0% | 0.000 | X² | ||||
(+) | 31 | 83.8% | 9 | 25.0% | |||||||
JAWS TRAC | (-) | 6 | 16.2% | 30 | 83.3% | 0.000 | X² | ||||
(+) | 31 | 83.8% | 6 | 16.7% | |||||||
Mask Ventilation | (-) | 33 | 89.2% | 36 | 100.0% | 0.115 | X² | ||||
(+) | 4 | 10.8% | 0 | 0.0% | |||||||
Bradycardia | (-) | 34 | 91.9% | 16 | 44.4% | 0.000 | X² | ||||
(+) | 3 | 8.1% | 20 | 55.6% | |||||||